Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph early_phase_1
1
33%
Ph not_applicable
1
33%
Ph phase_4
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Other(3)

Detailed Status

unknown3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown3100%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Assessment of Vital Pulp Therapy in Permanent Molars

NCT03410134
unknownearly_phase_1

Color Stability of NeoMTA Pulpotomized Primary Teeth

NCT03254290
unknownphase_4

Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT

NCT02702505

Clinical Trials (3)

Showing 3 of 3 trials
NCT03410134Not Applicable

Assessment of Vital Pulp Therapy in Permanent Molars

Unknown
NCT03254290Early Phase 1

Color Stability of NeoMTA Pulpotomized Primary Teeth

Unknown
NCT02702505Phase 4

Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3